TOI - NASDAQ
The Oncology Institute, Inc.
$4.59
-7.8%The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
At a Glance
Live Snapshottoi
Cost of Revenue
Last Annual Value
433.24M
3-Year CAGR
29%
5-Year CAGR
24%
10-Year CAGR
17%
The Oncology Institute, Inc. Competitors Analysis of Cost of Revenue
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
The Oncology Institute, Inc. NASDAQ:TOI | 433.24M | 17.9% | 21.7% | N/A | |
 OrthoPediatrics Corp. NASDAQ:KIDS | 63.69M | 19.3% | 20.9% | 19.3% | |
 Treace Medical Concepts, Inc. NASDAQ:TMCI | 42.94M | 6.9% | 20.5% | N/A | |
 Aura Biosciences, Inc. NASDAQ:AURA | 0.00 | N/A | N/A | N/A | |
 Community Health Systems, Inc. NYSE:CYH | 11.40B | 15.5% | 9.4% | -0.2% | |
 Design Therapeutics, Inc. NASDAQ:DSGN | 622.00K | 5.0% | N/A | N/A | |
 Semler Scientific, Inc. NASDAQ:SMLR | 4.76M | -12.0% | -4.9% | 9.8% | |
 Talkspace, Inc. NASDAQ:TALK | 130.52M | 19.9% | 22.7% | N/A | |
 Perspective Therapeutics, Inc. AMEX:CATX | 3.25M | N/A | -12.1% | -1.9% | |
 Senseonics Holdings, Inc. NASDAQ:SENS | 19.49M | 0.3% | 6.1% | 40.3% | |
 Cross Country Healthcare, Inc. NASDAQ:CCRN | 857.52M | -18.2% | -8.0% | 3.4% |
The Oncology Institute, Inc. Fair Value Envelope
Related Guides
Continue your TOI research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.